PubRank

I R Williams

Author PubWeight™ 51.51‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Leukocytosis and resistance to septic shock in intercellular adhesion molecule 1-deficient mice. J Exp Med 1994 3.32
2 Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL/JAK2. Mol Cell 2000 2.41
3 Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myelo- and lymphoproliferative disease in mice by retrovirally transduced TEL/JAK2 fusion genes. EMBO J 1998 2.38
4 Microfold (M) cells: important immunosurveillance posts in the intestinal epithelium. Mucosal Immunol 2013 1.57
5 Signal transduction and transforming properties of the TEL-TRKC fusions associated with t(12;15)(p13;q25) in congenital fibrosarcoma and acute myelogenous leukemia. EMBO J 2000 1.44
6 The Otto Aufranc Award. Impact of gamma sterilization on clinical performance of polyethylene in the hip. Clin Orthop Relat Res 1995 1.32
7 The prognosis of primary intracerebral tumours presenting with epilepsy: the outcome of medical and surgical management. J Neurol Neurosurg Psychiatry 1991 1.31
8 Keratinocyte-derived monocyte chemoattractant protein 1 (MCP-1): analysis in a transgenic model demonstrates MCP-1 can recruit dendritic and Langerhans cells to skin. J Invest Dermatol 1995 1.28
9 Fatal myeloproliferation, induced in mice by TEL/PDGFbetaR expression, depends on PDGFbetaR tyrosines 579/581. J Clin Invest 2000 1.21
10 TEL/PDGFbetaR induces hematologic malignancies in mice that respond to a specific tyrosine kinase inhibitor. Blood 1999 1.19
11 The tradeoffs associated with modular hip prostheses. Clin Orthop Relat Res 1995 1.14
12 H4(D10S170), a gene frequently rearranged in papillary thyroid carcinoma, is fused to the platelet-derived growth factor receptor beta gene in atypical chronic myeloid leukemia with t(5;10)(q33;q22). Blood 2001 1.11
13 Neuropathy associated with hepatitis in patients maintained on haemodialysis. Br Med J 1972 1.09
14 Acute induction of human IL-8 production by intestinal epithelium triggers neutrophil infiltration without mucosal injury. Gut 2005 1.09
15 Differences between neurological and neurosurgical approaches in the management of malignant brain tumours. Br Med J (Clin Res Ed) 1986 1.08
16 Peripheral nerve conduction in patients with a cervical rib and band. Ann Neurol 1978 1.08
17 Development of prognostic index for primary supratentorial intracerebral tumours. J Neurol Neurosurg Psychiatry 1992 1.08
18 Inflammatory and hyperproliferative skin disease in mice that express elevated levels of the IL-1 receptor (type I) on epidermal keratinocytes. Evidence that IL-1-inducible secondary cytokines produced by keratinocytes in vivo can cause skin disease. J Clin Invest 1996 1.06
19 M cell-depletion blocks oral prion disease pathogenesis. Mucosal Immunol 2012 1.03
20 Donor lymphoid organs are a major site of alloreactive T-cell priming following intestinal transplantation. Am J Transplant 2006 1.01
21 CCR6 identifies lymphoid tissue inducer cells within cryptopatches. Clin Exp Immunol 2010 0.98
22 Assessment of depression in patients with motor neuron disease and other neurologically disabling illness. J Neurol Sci 1997 0.97
23 Extrajunctional acetylcholine sensitivity of inactive muscle fibres in the baboon during prolonged nerve pressure block. J Physiol 1978 0.96
24 Overview of polyethylene as a bearing material: comparison of sterilization methods. Clin Orthop Relat Res 1996 0.96
25 Peripheral motor nerve function in diabetic autonomic neuropathy. J Neurol Neurosurg Psychiatry 1976 0.95
26 Regeneration distal to a prolonged conduction block. J Neurol Sci 1977 0.94
27 Subacute proximal diabetic neuropathy. Neurology 1976 0.91
28 Regulation of transplantation immunity in vivo by monoclonal antibodies recognizing host class II restriction elements. I. Genetics and specificity of anti-Ia immunotherapy in murine skin allograft recipients. J Immunol 1985 0.89
29 The management of patients with an intrinsic supratentorial brain tumour. Br J Neurosurg 1990 0.89
30 The functional maturation of M cells is dramatically reduced in the Peyer's patches of aged mice. Mucosal Immunol 2013 0.88
31 Prediction of alcohol-related harm from controlled drinking strategies and alcohol consumption trajectories. Addiction 2004 0.86
32 Acute nerve compression during limb ischaemia--an experimental study. J Neurol Sci 1980 0.84
33 The role of vertebral angiography in the investigation of third nerve palsy. J Neurol Neurosurg Psychiatry 1981 0.83
34 Incrementing responses in myasthenia gravis. Arch Neurol 1974 0.82
35 Cutaneous interleukin-7 transgenic mice display a propitious environment to Schistosoma mansoni infection. Parasite Immunol 2001 0.81
36 Quantification of third body damage to the tibial counterface in mobile bearing knees. Proc Inst Mech Eng H 2001 0.81
37 Treatment of parkinsonism by amantadine and levodopa. Clin Pharmacol Ther 1972 0.80
38 Acetylcholine-sensitivity of denervated and inactivated baboon muscle fibres [proceedings]. J Physiol 1977 0.79
39 Induction of myeloproliferative disease in mice by tyrosine kinase fusion oncogenes does not require granulocyte-macrophage colony-stimulating factor or interleukin-3. Blood 2001 0.78
40 Controlled overexpression of BCKD kinase expression: metabolic engineering applied to BCAA metabolism in a mammalian system. Metab Eng 2000 0.78
41 The effect of afferent stimuli on steadily discharging single motor units in man. J Neurol Neurosurg Psychiatry 1981 0.78
42 Regulation of transplantation immunity in vivo by monoclonal antibodies recognizing host class II restriction elements. II. Effects of anti-Ia immunotherapy on host T cell responses to graft alloantigens. J Immunol 1985 0.78
43 A double determinant sandwich immunoassay for quantitation of serum monoclonal anti-I-A antibody. J Immunol Methods 1985 0.78
44 Suppressor T cell recognition of major and minor histocompatibility alloantigens: selected suppression of MHC-directed responses by minor alloantigen Ts. J Immunol 1984 0.77
45 Distinct roles for B7 costimulation in contact hypersensitivity and humoral immune responses to epicutaneous antigen. Eur J Immunol 1998 0.77
46 The folate status of alcoholics. Scott Med J 1970 0.76
47 Neurological and neurosurgical approaches in the management of malignant brain tumours. Br Med J (Clin Res Ed) 1986 0.75
48 Neurological and neurosurgical approaches in the management of malignant brain tumours. Br Med J (Clin Res Ed) 1987 0.75
49 Disease progression and perceptions of health in patients with motor neurone disease. J Neurol Sci 1995 0.75
50 The generation of wear debris from cementless hip prostheses. Instr Course Lect 1994 0.75
51 Variability of neuromuscular transmission in myasthenia gravis. Trans Am Neurol Assoc 1973 0.75
52 Lack of effect of folic-acid administration on cerebral metabolism. Lancet 1971 0.75
53 Consensus on HIV testing. BMJ 1988 0.75
54 Unrecognised Cushing's syndrome and adrenal suppression due to topical clobetasol propionate. Br J Clin Pract 1991 0.75
55 Opsoclonus-myoclonus syndrome: an autopsy study of three cases. Eur J Med 1993 0.75